Company intelligence / Profile preview

LinkoCare

Solna, Stockholm County, Swedenlinkocare.com ↗

Ownership: Private
Development stage: Commercial

Overview

A pilot phase I clinical study in 20 patients with advanced corneal disease showed strong efficacy signals. Fourteen participants who were legally blind prior to implantation regained vision and none remained legally blind at two years’ follow-up. The implants are safe, effective, and can be stored up to two years before use. Larger trials are planned to support regulatory approval.

Therapeutic areas: Ophthalmology
Modalities: BiologicRecombinant proteinMedical device (bioengineered corneal implant)
Industry: Implantable Medical Devices

Drug pipeline

2 assets

Bioengineered full-thickness corneal implant

Commercial

Indications: Corneal blindness

1 more asset in the full pipeline.

Request access →

Partnerships

Care Group India (supported manufacturing/testing)

Beyond the preview

Go deeper on LinkoCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LinkoCare.

Explore the full profile